Biotech company Clinical Genomics raises US$15 million round led by OneVentures

Clinical Genomics, a biotechnology company working across the United States and Australia, has closed a US$15 million ($19.7 million) round led by Sydney-based VC firm OneVentures. Dr Paul Kelly, partner at and managing director of OneVentures and former CEO of biotech company Gemini Genomics, will join the company’s board of directors.

Learn More

Posted in — Startup Daily


You may also like

25 August 2020

Subscription e-bike venture Bolt Bikes raises $16 million as it rebrands and expands globally

22 March 2016

Biotech company Clinical Genomics raises US$15 million round led by OneVentures

13 March 2013

TheBestDay closes $1million dollar funding round

View All

Ventured. Gained.

Subscribe to our Newsletter for the latest updates from 1V.

decor decor decor
decor decor decor decor decor
clear Close